Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy

被引：32

作者：

Jain, RK ^{[1
]}

Padera, TP ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, EL Steele Lab,Dept Radiat Oncol, Boston, MA 02114 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2002年 / 94卷 / 11期

关键词：

D O I：

10.1093/jnci/94.11.785

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：785 / 787

页数：3

共 33 条

[1] Molecular mechanisms of lymphangiogenesis in health and disease [J].

Alitalo, K ;

Carmeliet, P .

CANCER CELL, 2002, 1 (03) :219-227

[2]

Beasley NJP, 2002, CANCER RES, V62, P1315

[3]

Birner P, 2000, ANTICANCER RES, V20, P2981

[4]

Birner P, 2001, INT J CANCER, V95, P29, DOI 10.1002/1097-0215(20010120)95:1<29::AID-IJC1005>3.0.CO

[5]

2-W

[6]

Birner P, 2001, CLIN CANCER RES, V7, P93

[7] Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features [J].

Bunone, G ;

Vigneri, P ;

Mariani, L ;

Butó, S ;

Collini, P ;

Pilotti, S ;

Pierotti, MA ;

Bongarzone, I .

AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1967-1976

[8]

deWaal RMW, 1997, AM J PATHOL, V150, P1951

[9]

Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257

[10]

Gunningham SP, 2000, CLIN CANCER RES, V6, P4278

← 1 2 3 4 →